Employees Provident Fund Board’s Biogen BIIB Stock Holding History

Employees Provident Fund Board’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$152M	Hold	704,196	–	–	0.87%	32
2026 Q1	$129M	Hold	704,196	–	–	0.98%	36
2025 Q4	$124M	Hold	704,196	–	–	0.91%	36
2025 Q3	$98.6M	Hold	704,196	–	–	0.79%	37
2025 Q2	$88.4M	Hold	704,196	–	–	0.76%	39
2025 Q1	$96.4M	Hold	704,196	–	–	1.09%	41
2024 Q4	$108M	Buy	704,196 +26,116	+4%	+$4.4M	1.34%	32
2024 Q3	$131M	Hold	678,080	–	–	1.8%	14
2024 Q2	$157M	Hold	678,080	–	–	2.52%	7
2024 Q1	$146M	Buy	678,080 +113,807	+20%	+$26.7M	2.57%	8
2023 Q4	$146M	Buy	564,273 +121,857	+28%	+$29.9M	2.85%	6
2023 Q3	$114M	Buy	442,416 +154,916	+54%	+$41.4M	2.58%	8
2023 Q2	$81.9M	Sell	287,500 -57,500	-17%	-$17.1M	1.94%	19
2023 Q1	$95.9M	Hold	345,000	–	–	2.48%	14
2022 Q4	$95.5M	Sell	345,000 -47,680	-12%	-$13.5M	2.76%	10
2022 Q3	$105M	Hold	392,680	–	–	3.06%	10
2022 Q2	$80.1M	Buy	392,680 +37,362	+11%	+$7.64M	1.81%	17
2022 Q1	$74.8M	Buy	355,318 +142,749	+67%	+$31M	1.28%	29
2021 Q4	$51M	Hold	212,569	–	–	0.84%	41
2021 Q3	$60.2M	Hold	212,569	–	–	0.99%	40
2021 Q2	$73.6M	Buy	212,569 +10,500	+5%	+$3.18M	1.21%	33
2021 Q1	$56.5M	Hold	202,069	–	–	0.97%	38
2020 Q4	$49.5M	Buy	202,069 +38,709	+24%	+$9.99M	0.84%	42
2020 Q3	$46.3M	Hold	163,360	–	–	0.97%	36
2020 Q2	$43.7M	Buy	163,360 +131,474	+412%	+$39.5M	0.99%	36
2020 Q1	$10.1M	Sell	31,886 -18,114	-36%	-$5.5M	0.27%	54
2019 Q4	$14.8M	Buy	+50,000	New	+$13.9M	0.31%	51

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Employees Provident Fund Board's BIIB Position: Q2 2026 in Review

Employees Provident Fund Board held its Biogen (BIIB) position steady in Q2 2026 at 704,196 shares worth $152M. The position accounts for 0.87% of the portfolio, ranked #32.

Employees Provident Fund Board first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. The position peaked at $157M in Q2 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Employees Provident Fund Board held 704,196 shares of Biogen worth $152M as of Q2 2026.
Employees Provident Fund Board left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.87% of Employees Provident Fund Board's portfolio in Q2 2026, its #32 holding.
Employees Provident Fund Board first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
Employees Provident Fund Board's Biogen position peaked at $157M in Q2 2024.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.